Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Unknown 2Completed 1

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Squamous Cell Carcinoma of Head and Neck 1Locally Advanced Head and Neck HPV Negative Squamous Cell Cancers 1Hypoxia 1

Interventions

Cisplatin 130Radiotherapy 94Carboplatin 85Fluorouracil 79Paclitaxel 78Cyclophosphamide 77Gemcitabine 72Capecitabine 66Docetaxel 65Doxorubicin 60Oxaliplatin 59Etoposide 57Leucovorin 50Vincristine 47Chemotherapy, Adjuvant 42Cytarabine 38Dexamethasone 35Drug Therapy 33Bevacizumab 31Epirubicin 29Neoadjuvant Therapy 28Pemetrexed 27Tamoxifen 25Irinotecan 25Prednisone 24Rituximab 21Methotrexate 21Radiotherapy, Intensity-Modulated 19apatinib 18Vinorelbine 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Nimorazole × Clear all
NCT01880359 2022-05-10

AF CRT +/- Nimorazole in HNSCC

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Unknown
640 enrolled
Head & Neck

Locally Advanced Head and Neck HPV Negative Squamous Cell Cancers

NCT02661152 2021-04-13

DAHANCA30

Danish Head and Neck Cancer Group

Phase 3 Unknown
1,252 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Hypoxia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡